Jeevitha Afm PPT Presentation

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 11

ADVANCE FINANCIAL

MANAGEMENT AND
PRACTICE
ASSIGNMENT

PRESENTED BY:
JEEVITHA.P
1ST SEM MCOM
INDUSTRY OF THE COMPANY:
HOSPITAL AND HEALTHCARE SERVICES

COMPANY DESCRIPTION:
APOLLO VISION STATEMENT Apollo’s vision for the next phase of development is to
‘Touch a Billion Lives’.
HOSPITALS  MISSION STATEMENT “Our mission is to bring healthcare of International
standards within the reach of every individual. We are committed to the
achievement and maintenance of excellence in education, research and healthcare
for the benefit of humanity”
 Apollo Hospitals Enterprise Ltd (Apollo Hospitals) is a healthcare service
provider. It offers healthcare services, clinical and diagnostic services, medical
business process outsourcing, third party administration services and health
insurance. The company also provides services to support business, telemedicine
services, education, training programs and research services and other non-profit
projects. Apollo Hospitals offers treatment for heart diseases, orthopaedic
diseases, diseases of spinal cord, cancer, gastroenterological diseases, neurological
diseases, and urological diseases, kidney diseases, and critical care and preventive
health care. The company has 71 hospitals, 4,118 pharmacies, over 172 primary
care and diagnostic clinics and 148 telemedicine units across 13 countries. It
operates hospitals in India, Bangladesh, Mauritius and the UK. Apollo Hospitals is
headquartered in Chennai, Tamil Nadu, India. Apollo hospitals enterprise ltd is
listed under NSE .The current market price of Apollo Hospitals is Rs.4304.75(as
on 02 MAY 2022, 3:59:27 pm).P/E ratio: 54.57.
 CAPITAL STRUCTURE OF THE COMPANY:

 CURRENT WORKING CAPITAL OF THE COMPANY:


1. Apollo Hospitals Group has launched Project Kavach to
tackle the COVID-19 pandemic (24rt MAR 2020):

Apollo Hospitals operates 71 hospitals (10,261 beds), 237 outpatient clinics,


 RECENT 3,766 retail pharmacies, a telehealth network covering 125 sites, and
several medical educational institutions. Patients mostly come from middle-
MAJOR and upper-class segments with a mix of private pay (about half), insurance,
government schemes, and international patients.
PROJECTS In March 2020, after a month of intense planning and diligence, Apollo
launched “Project Kavach” (meaning “shield” in Hindi), a multipronged
OF THE program to tackle the Covid-19 pandemic. While the core underlying
COMPANY: principles were similar to those employed by U.S. health systems, Kavach
was designed to overcome some unique challenges through innovative new
health delivery approaches.
In the early days of the pandemic, Apollo had to rapidly standardize
protocols across its 71 hospitals, in anticipation of a large volume of Covid-
19 patients and to avoid disrupting the care of people with other conditions.
Apollo employs approximately 80,000 people, including some 11,500 nurses
(of whom 14% worked with Covid-19 patients). Many staff lived in
relatively small joint-family homes where they could not easily isolate
themselves and so staff welfare was a priority.
2. Apollo Hospitals to set up its first multi-speciality
hospital in Jammu and Kashmir soon (29th Dec 2021):

Apollo Hospitals will set up its first 250-bed multi-speciality


hospital in J&K’s Jammu region soon. An official spokesperson
said the J&K government on Tuesday signed a memorandum of
understanding with the renowned healthcare company Apollo
hospitals for the establishment of a multi-speciality hospital in
Jammu.
The MoU was signed between Ranjan prakash Thakur, principal
secretary to J&K government, industries and commerce and
department and Dr. Preetha reddy, executive vice chairperson,
Apollo hospitals enterprise ltd, in the presence of J&K lieutenant
governor Manoj Sinha.
3. Apollo Hospitals inks pact for tertiary care hospital in
Uzbekistan (17th FEB 2022):

The Apollo Hospitals inked a pact with Marafon Group for setting up a


first-of-its kind tertiary care hospital in Uzbekistan, the leading
corporate hospital said on Thursday.
The partnership with Apollo Hospitals will provide quality healthcare
for over 60 million people of Uzbekistan and bordering regions of
Kyrgyzstan, Kazakhstan and Tajikistan, the private healthcare services
provider, which is expanding its presence to the Central Asian country,
said.
Uzbekistan is known for its mosques, mausoleums and other heritage
sites.
Announcing the partnership, Dr Prathap C Reddy, founder &
chairman, Apollo Hospitals India, said the group hopes to touch a billion
lives across the globe and also ensure the Apollo clinical excellence
globally.
MERGER:
Apollo Hospitals have mergers with its group companies Deccan Hospitals, Hyderabad,
and Indian Hospital Corporation, Chennai, along with Sindhoori Hotels, Chennai, to
emerge as the leading healthcare unit in Asia.

The Company has approved to issue up to 20,00,000 No. of equity shares of Rs.10 each on
private placement basis to FIIs, MFs, FIs and banks etc, at or above the price calculated in
accordance with SEBI Guidelines.

 MERGER
Apollo Hospitals forms Apollo Health Co with merger of four businesses
AND (23rd June 2021):
AQUISITION:
AHEL underwent a restructuring by merging business such as AHEL's back-end offline
pharmacy business (excluding hospital-based pharmacies); AHEL's digital healthcare
platform Apollo 24/7; AHEL's investment in retail pharmacy business (Apollo Medicals
Private Ltd); and Apollo 24/7 brand .This platform will combine the strengths of Apollo
Group's offline healthcare leadership with Apollo Group's new-age digital offerings to
address all healthcare consumer needs .The offline pharmacy business of AHEL will
continue to grow to 5,000 stores and maintain a healthy revenue growth rate of 18-20 per
cent in the next 3 years. The margin trajectory of this business remains intact. In addition,
the digital healthcare platform Apollo 24/7, has demonstrated the capability of delivering
medicines in 2 hours in over 10,000 pin codes combined with the highest availability of
medicines. Apollo 24/7 aspires to achieve 100 million registered users in five years.
ACQUISITION:
Overview of Apollo Hospital’s Acquisitions
1. Apollo Hospitals All Acquisitions: 3
has made 3     

acquisitions and 5 Latest Acquisitions: Huge Domains (Jul 2018), Nova Specialty Hospitals (Jan
2015), Hetero Pharmacy (Sep 2014)
investments. The
Key Acquisition: Hetero Pharmacy (Acq. for $ 24M in Sep 2014),
company has spent Huge Domains (Acq. for $ 13M in Jul 2018)
over $ 37M for the
acquisitions. Apollo
Hospitals has DATE COMPANY AMOUNT LOCATION
     
invested in multiple  Apollo 05 JUL 2018 HUGE DOMAINS USD 13M
      DENVER UNITED
sectors such as and Hospital       STATES
  NOVA  
more. Recent   SPECIALITY  
  Acquisition: O6 JAN 2015
 
HOSPITAL
 
UNDISCLOSED
 
BANGLORE
INDIA
     
  HETERO  
17 SEP 2014 PHARMACY USD 24M
HYDERABAD
INDI
2. Apollo Hospitals eyes smaller acquisitions of up to Rs 300
crore (25th SEP 2019)

3. Apollo Hospitals scouting for acquisitions in north and east


India (19th NOV 2020):

The hospital chain recently got its board's approval to raise up


to Rs 1,500 crore and a portion of it will be used for acquisitions.
Apollo signed a definitive share purchase agreement with IHH,
its JV partner in Apollo Gleneagles Hospitals, Kolkata, to
acquire its existing 50 per cent stake in AGHL for a cash
purchase consideration of Rs 410 crore.
For the year ending March 2021 Apollo Hospitals Enterprises has
declared an equity dividend of 60.00% amounting to Rs 3 per share. At
the current share price of Rs 4304.75 this results in a dividend yield of
0.07%.
The company has a good dividend track report and has consistently
declared dividends for the last 5 years.
Announcement
Ex-Date Dividend Type Dividend (%) Dividend (Rs) Remarks
Date

23-06-2021 18-08-2021 Final 60 3.00 Rs.3.0000 per share


(60%) Dividend

 DIVIDEND 25-06-2020 17-09-2020 Final 55 2.75 Rs.2.7500 per share

POLICY:
(55%) Final
Dividend

13-02-2020 25-02-2020 Interim 65 3.25 Rs.3.2500 per share


(65%) Interim
Dividend

30-05-2019 12-09-2019 Final 120 6.00 Rs.6.0000 per share


(120%) Dividend
(Revised)

30-05-2018 12-09-2018 Final 100 5.00 Rs.5.0000 per share


(100%) Dividend

You might also like